======= EBF3 ======= == Gene Information == * **Official Symbol**: EBF3 * **Official Name**: EBF transcription factor 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=253738|253738]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H4W6|Q9H4W6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EBF3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EBF3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607407|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the early B-cell factor (EBF) family of DNA binding transcription factors. EBF proteins are involved in B-cell differentiation, bone development and neurogenesis, and may also function as tumor suppressors. The encoded protein inhibits cell survival through the regulation of genes involved in cell cycle arrest and apoptosis, and aberrant methylation or deletion of this gene may play a role in multiple malignancies including glioblastoma multiforme and gastric carcinoma. [provided by RefSeq, Sep 2011]. * **UniProt Summary**: Transcriptional activator (PubMed:28017373, PubMed:28017372, PubMed:28017370). Recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3' (By similarity). {ECO:0000250|UniProtKB:Q07802, ECO:0000269|PubMed:28017370, ECO:0000269|PubMed:28017372, ECO:0000269|PubMed:28017373}. |TIG| |protein dimerization activity| |DNA-binding transcription activator activity, RNA polymerase II-specific| |RNA polymerase II proximal promoter sequence-specific DNA binding| |positive regulation of transcription by RNA polymerase II| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp145|PNU96415E 10μM R03 exp145]]|-2.05| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|-1.84| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-1.81| |[[:results:exp219|A-395N 10μM R05 exp219]]|-1.76| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.73| |[[:results:exp447|Amiloride 100μM R08 exp447]]|1.94| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15242 * **Expression level (log2 read counts)**: 1.06 {{:chemogenomics:nalm6 dist.png?nolink |}}